Fresenius Kabi

FULVESTRANT

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Fresenius Kabi

Fulvestrant HCPCS:

J9394

HCPCS Code Descriptor:

Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg

Category:

J Code

Fulvestrant NDCs:

63323-0715-05

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Syringe

Route of Administration:

Intramuscular

Fulvestrant CPT Codes:

Potential CPT administration codes for Fulvestrant can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

63323-0715-05

About Fulvestrant:

FULVESTRANT is an Oncology drug manufactured by Fresenius Kabi and administered via the Intramuscular route of administration. The J Code: J9394 is aligned to the drug FULVESTRANT.

ACCESS PRICING AND MORE BY REGISTERING

J9394 Added Date:

January 1, 2023

J9394 Effective Date:

January 1, 2023

J9394 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Fulvestrant billing and coding information.
Fulvestrant patient assistance information can be found through KabiCare at the URL: https://kabicare.us/
FULVESTRANT prescribing information can be found at the link below:
Information regarding FULVESTRANT’s side effects can be found at MedlinePlus